Abstract
Photodynamic therapy is useful due to its high antitumor efficacy, spatiotemporal selectivity, and noninvasiveness and has garnered significant attention in the field of cancer treatment. When photoexcited by light irradiation, photosensitizers produce reactive oxygen species (ROS) that damage tumor tissues. However, photosensitizers can also accumulate in normal tissues, leading to side effects such as skin photosensitivity. To mitigate these side effects, we report the development of chlorophyll‒peptide conjugates as tumor-selective photosensitizers. These conjugates bearing histidine and lysine residues self-assemble into nanoparticles that are expected to accumulate selectively in tumors and reduce ROS generation through self-quenching under the neutral conditions typical of normal tissues. In contrast, these aggregated conjugates partially disassemble under weakly acidic conditions, such as those found in tumor tissues, resulting in phototoxicity. We anticipate that these acid-activatable conjugates have the potential to serve as cancer-selective photosensitizers, thereby reducing phototoxicity in normal tissues.
Similar content being viewed by others
Introduction
Photodynamic therapy (PDT) using photosensitizers has garnered attention in the field of cancer treatment because of its high antitumor efficacy, negligible systemic toxicity, spatiotemporal selectivity, and noninvasiveness [1,2,3]. When administered to a body and illuminated with light, photosensitizers generate reactive oxygen species (ROS), mainly singlet oxygen, via intersystem crossing to damage tumor tissues. Although Photofrin® and Laserphyrin® have been commercialized for PDT [4,5,6,7], there remains a risk of skin photosensitivity even in sunlight due to the accumulation of photosensitizers in normal tissues [6, 8]. This is because ROS generation is not cancer-selective; ROS are produced in the presence of light, photosensitizers, or oxygen (3O2). Thus, the side effects of PDT, as well as its therapeutic benefits, depend on the accumulation of photosensitizers, necessitating tumor-selective photosensitizers that preferentially accumulate in tumor tissues over normal tissues.
The unique features of tumors, such as vascular permeability from impaired blood vessels and weak acidity from overexpressed lactic acid, known as the Warburg effect, present opportunities for selective targeting [9,10,11]. Nanoparticles with diameters of 10–200 nm can selectively accumulate in tumor tissues, a phenomenon known as the enhanced permeability and retention (EPR) effect [9, 12]. In addition to passive targeting strategies [13,14,15,16,17,18,19,20], recent developments have focused on activity-controllable photosensitizers triggered by the biochemical hallmarks of tumors, including acidity and overexpressed compounds in cancer cells [21,22,23,24,25,26,27]. These activatable photosensitizers are designed to be in an “OFF state” in normal tissues, where ROS generation by light irradiation is minimized; they are turned to the “ON state” and become active in tumor microenvironments or when exposed to external stimuli such as light, heat, or magnetism. Both passive targeting and active control methods are effective approaches for reducing side effects, such as skin photosensitivity, associated with PDT.
We report the development of chlorophyll‒peptide conjugates as photosensitizers, which combine passive targeting based on the EPR effect with environmentally responsive properties and operate selectively in weakly acidic environments such as tumor tissues (Fig. 1). Chlorophyll derivatives, characterized by a chlorin π-skeleton, exhibit significant absorption in the far-red and near-infrared regions [28] and have been effectively used as photodynamic therapeutic agents [29,30,31]. These derivatives produce ROS when exposed to light in their monomeric state, while their aggregation significantly reduces their phototoxicity through self-quenching. We focused on the aggregation-dependent photophysical properties of chlorophyll derivatives and the unique tumor microenvironments, including vascular permeability and weak acidity, to design chlorophyll‒peptide conjugates that self-aggregate under neutral conditions and disaggregate under acidic conditions. In this strategy, the aggregated conjugates with reduced phototoxicity due to self-quenching circulate in the blood, which is neutral, and selectively accumulate in tumor tissues with defective structures (Fig. 1a). In weakly acidic tumor tissues, the aggregated conjugates disassemble due to electrostatic repulsion caused by the protonation of peptide moieties, resulting in increased phototoxicity (Fig. 1b).
Our chlorophyll‒peptide conjugates are composed of short peptides and a chlorophyll derivative, which exhibit low immunogenicity, good biodegradability, and high biocompatibility and can be easily synthesized by solid-phase synthesis [32,33,34,35]. These conjugates self-assemble to form nanoparticles, facilitating targeting via the EPR effect. The nanoparticles showed reduced ROS generation and cytotoxicity under neutral conditions upon photoirradiation but exhibited significant phototoxicity under weakly acidic conditions. We anticipate that variations in the physical properties of the conjugates, such as the aggregate size and ROS generation ability, with different peptides will provide valuable insights for designing novel photosensitizers. Acid-activatable conjugates hold promise as cancer-selective photosensitizers capable of reducing phototoxicity in normal tissues.
Experimental procedure
General
1H-NMR spectra were recorded in DMSO-d6 (containing 0.05% (w/v) tetramethylsilane (TMS)) via a Bruker Avance III (400 MHz) spectrometer. The internal standard for these measurements was TMS, with a chemical shift (δH) of 0.00 ppm. Laser desorption/ionization-time of flight (LDI-TOF) mass spectra were recorded using a JEOL JMS-S3000plus2 spectrometer. Ultraviolet‒visible (UV‒vis) absorption and fluorescence emission spectra were measured in solution with a 10 mm quartz cell at room temperature via a Shimadzu UV-3600 spectrophotometer and a Shimadzu RF-5300PC spectrophotometer, respectively. Transmission electron microscopy (TEM) was performed on a JEOL JEM-z2500 microscope at an acceleration voltage of 200 kV. Dynamic light scattering (DLS) measurements were conducted via a Malvern Zetasizer Nano ZS at 25 °C in a 10 mm disposable cell. All the reaction reagents, solvents, amino acids, and base resins used for peptide synthesis were obtained from commercial suppliers and utilized as supplied.
Synthesis of Chl-H5
Chl-H5 was synthesized via solid-phase peptide synthesis using CLEAR-Amide Resin (100–200 mesh). The resin (400 mg, 0.42 meq/g) was initially swollen in CH2Cl2 (5 mL) for 12 h and then washed with N,N-dimethylformamide (DMF, 5 mL × 3 times). Fmoc-protected histidine, 1-hydroxy-7-azabenzotriazole, and 1,3-diisopropylcarbodiimide (3 eq. each) were dissolved in DMF (5 mL) and added to a reaction flask. The flask was agitated for 2 h, and the resin was washed with DMF (5 mL × 3 times). For deprotection of the Fmoc group, a 20% (v/v) piperidine/DMF solution (5 mL) was added to the reaction flask and agitated for 20 min. The resulting resin was washed with DMF (5 mL × 3 times) after the deprotection process. After all the amino acids were coupled, pyropheophorbide-a was condensed in the aforementioned fashion. The conjugate was cleaved from the resulting resin by treatment with an aqueous 95% (v/v) trifluoroacetic acid (TFA) solution for 2 h. After the solvents were evaporated in vacuo, cold Et2O was added to the residue to yield dark green precipitates. The solids were dried, dispersed in H2O, and lyophilized to obtain Chl-H5.
1H-NMR (400 MHz, DMSO-d6) δH = 9.78 (1H, s, 10-H), 9.50 (1H, s, 5-H), 8.88 (1H, s, 20-H), 8.89–8.76 (5H, m, 2-H of His), 8.26 (1H, dd, J = 12, 18 Hz, 3-CH), 7.32–7.21 (5H, m, 5-H of His), 6.41 (1H, d, J = 18 Hz, trans-31-CH), 6.24 (1H, d, J = 12 Hz, cis-31-CH), 5.16, 5.08 (each 1H, d, J = 20 Hz, 131-CH2), 4.54 (1H, q, J = 7 Hz, 18-H), 4.30 (1H, d, J = 8 Hz, 17-H), 3.74 (2H, q, J = 7 Hz, 8-CH2), 3.64 (3H, s, 12-CH3), 3.45 (3H, s, 2-CH3), 3.25 (3H, s, 7-CH3), 3.14–2.89 (10H, m, Cα-CH2 of His), 2.43–2.31, 2.12–2.06 (1H + 2H, m, 17-CH2CH2), 1.77 (3H, d, J = 7 Hz, 18-CH3), 1.64 (3H, t, J = 7 Hz, 81-CH3), 0.34, –1.90 (each 1H, s, NH of chlorin macrocycle). [One proton peak in 17-CH2CH2 overlapped with a solvent peak. Imidazole-NH, amide-NH, and peptidyl Cα-H peaks were not detected.] MS (LDI) results were as follows: m/z = 1219.5, 1241.5 (calcd for C63H71N20O7: 1219.6 [M + H]+, C63H70N20O7Na: 1241.6 [M+Na]+).
Synthesis of Chl-(HK)2H
Chl-(HK)2H was obtained as a dark green solid via the same procedure used for Chl-H5 synthesis.
1H-NMR (400 MHz, DMSO-d6) δH = 9.79 (1H, s, 10-H), 9.50 (1H, s, 5-H), 8.90 (1H, s, 20-H), 8.89–8.79 (3H, m, 2-H of His), 8.26 (1H, dd, J = 12, 18 Hz, 3-CH), 7.45–7.20 (3H, m, 5-H of His), 6.42 (1H, d, J = 18 Hz, trans-31-CH), 6.24 (1H, d, J = 12 Hz, cis-31-CH), 5.19, 5.10 (each 1H, d, J = 20 Hz, 131-CH2), 4.57 (1H, q, J = 7 Hz, 18-H), 4.50 (1H, t, J = 7 Hz, 17-H), 4.33–4.12 (5H, m, Cα-H of peptide), 3.74 (2H, q, J = 7 Hz, 8-CH2), 3.65 (3H, s, 12-CH3), 3.44 (3H, s, 2-CH3), 3.25 (3H, s, 7-CH3), 3.14–2.80 (6H, m, Cα-CH2 of His), 2.35–2.31, 2.16–2.09 (1H + 2H, m, 17-CH2CH2), 1.78 (3H, d, J = 7 Hz, 18-CH3), 1.65 (3H, t, J = 7 Hz, 81-CH3), 1.57–1.18 (16H, m, Cα-(CH2)4 of Lys), 0.35, –1.90 (each 1H, s, NH of chlorin macrocycle). [One proton peak in 17-CH2CH2 overlapped with a solvent peak. Imidazole- and amide-NH peaks were not detected.] MS (LDI) results were as follows: m/z = 1202.5, 1223.5 (calcd for C63H80N17O8: 1201.7 [M + H]+, C63H79N17O8Na: 1223.6 [M+Na]+).
Synthesis of Chl-(KH)2K
Chl-(KH)2K was obtained as a dark green solid via the same procedure used for Chl-H5 synthesis.
1H-NMR (400 MHz, DMSO-d6) δH = 9.77 (1H, s, 10-H), 9.49 (1H, s, 5-H), 8.91 (1H, s, 20-H), 8.90–8.81 (2H, m, 2-H of His), 8.26 (1H, dd, J = 12, 18 Hz, 3-CH), 7.46–7.33 (2H, m, 5-H of His), 6.41 (1H, d, J = 18 Hz, trans-31-CH), 6.24 (1H, d, J = 12 Hz, cis-31-CH), 5.16, 5.11 (each 1H, d, J = 20 Hz, 131-CH2), 4.58 (1H, q, J = 7 Hz, 18-H), 4.35 (1H, d, J = 8 Hz, 17-H), 4.24–4.09 (5H, m, Cα-H of peptide), 3.73 (2H, q, J = 7 Hz, 8-CH2), 3.64 (3H, s, 12-CH3), 3.46 (3H, s, 2-CH3), 3.25 (3H, s, 7-CH3), 3.14–2.88 (4H, m, Cα-CH2 of His), 2.36–2.30, 2.20–2.12 (1H + 2H, m, 17-CH2CH2), 1.81 (3H, d, J = 7 Hz, 18-CH3), 1.64 (3H, t, J = 7 Hz, 81-CH3), 1.56–1.22 (24H, m, Cα-(CH2)4 of Lys), 0.35, –1.89 (each 1H, s, NH of chlorin macrocycle). [One proton peak in 17-CH2CH2 overlapped with a solvent peak. Imidazole- and amide-NH peaks were not detected.] MS (LDI) results were as follows: m/z = 1214.6, 1230.5 (calcd for C63H85N17O7Na: 1214.7 [M+Na]+, C63H85N17O7K: 1230.6 [M + K]+).
Synthesis of Chl-K5
Chl-K5 was obtained as a dark green solid via the same procedure used for Chl-H5 synthesis.
1H-NMR (400 MHz, DMSO-d6) δH = 9.79 (1H, s, 10-H), 9.50 (1H, s, 5-H), 8.91 (1H, s, 20-H), 8.27 (1H, dd, J = 12, 18 Hz, 3-CH), 6.42 (1H, d, J = 18 Hz, trans-31-CH), 6.24 (1H, d, J = 12 Hz, cis-31-CH), 5.22, 5.12 (each 1H, d, J = 20 Hz, 131-CH2), 4.59 (1H, q, J = 7 Hz, 18-H), 4.35 (1H, d, J = 8 Hz, 17-H), 4.25–4.14 (5H, m, Cα-H of Lys), 3.74 (2H, q, J = 7 Hz, 8-CH2), 3.65 (3H, s, 12-CH3), 3.46 (3H, s, 2-CH3), 3.26 (3H, s, 7-CH3), 2.35–2.31, 2.22–2.11 (1H + 2H, m, 17-CH2CH2), 1.81 (3H, d, J = 7 Hz, 18-CH3), 1.65 (3H, t, J = 7 Hz, 81-CH3), 1.72–1.14 (40H, m, Cα-(CH2)4 of Lys), 0.37, –1.88 (each 1H, s, NH of chlorin macrocycle). [One proton peak in 17-CH2CH2 overlapped with a solvent peak. Imidazole- and amide-NH peaks were not detected.] MS (LDI) results were as follows: m/z = 1174.7, 1196.7 (calcd for C63H96N15O7: 1174.8 [M + H]+, C63H95N15O7Na: 1196.7 [M+Na]+).
Preparation of self-assembled conjugates
The conjugate was dissolved in a small amount of ethanol (50 μL). A 20 nmol aliquot of the solution was transferred into test tubes to 20 nmol, and then the solvent was dried. After 2.0 mL of phosphate buffer solution (PBS) at pH 5.8 or 7.4 was added to the dried conjugates, the sample was ultrasonicated for 5 min to prepare self-aggregates dispersed in the PBS medium.
Evaluation of ROS generation
A total of 100 μg of singlet oxygen sensor green (SOSG) [36] was dissolved in 33 μL of MeOH and diluted with 16.467 mL of pure water to prepare an SOSG stock solution (10 μM). A total of 1.0 mL of the SOSG stock solution was added to 1.0 mL of the assembled conjugate dispersion in 1% (v/v) EtOH–PBS at pH 7.4 or 5.8 to obtain a sample for ROS evaluation. The sample was photoirradiated for 5 min (λ = 420 nm) with the light source of a SHIMADZU RF-5300PC fluorescence spectrophotometer, and then, ROS generation was evaluated by fluorescence emission spectroscopy with excitation at 410 nm.
Cytotoxicity test
The cytotoxicity of Chl-(HK)2H was evaluated via the propidium iodide (PI) exclusion test [37]. HeLa cells (1.0 × 105) were plated on 35 mm glass-bottom dishes and cultured for 24 h. The cells were treated with PI (1 µg/mL) at 37 °C. A preprepared dispersion of Chl-(HK)2H aggregates in PBS at pH 5.8 or 7.4 (10 μM) was added to the cell medium and adjusted to a concentration of 0.1 or 1 μM. For the dark cytotoxicity assay, the medium was changed to Dulbecco’s modified Eagle medium (pH 5.8 or 7.4), and the cells were incubated with Chl-(HK)2H at 0.1 or 1 μM. After 0–60 min, the cells were observed via fluorescence microscopy using an EVOS M5000 imaging system (Thermo Fisher Scientific) equipped with a LUCPLFLN20X objective lens (Olympus) and an EVOS Texas Red 2.0 light cube (Thermo Fisher Scientific). For the PDT study, HeLa cells treated with Chl-(HK)2H at 0.1 or 1 μM were photoirradiated (λ = 420 nm) with a 300 W xenon lamp (MAX-303, Asahi Spectra) equipped with an HMX0420 bandpass filter (Asahi Spectra) for 10–30 min. Cell viability was estimated by determining the percentage of non-PI-stained (live) cells relative to the total number of cells counted (n > 600 cells for each condition).
Results and discussion
Design and synthesis of chlorophyll‒peptide conjugates
We designed chlorophyll‒peptide conjugates that change their aggregation ability with varying pH, consisting of a pH-responsive peptide with histidine and/or lysine and a chlorophyll-a derivative, pyropheophorbide-a (Scheme 1, lower, center). Lysine is a hydrophilic amino acid that is constantly ionized under acidic and neutral conditions. The introduction of hydrophilic groups was required to improve the dispersibility of the aggregated conjugates in aqueous solution, so lysine residues with hydrophilic side chains were selected. Histidine is hydrophobic under neutral conditions but hydrophilic under acidic conditions due to the protonation of the imidazolyl side chain. Histidine residues were chosen because this pH-responsive change in hydrophilicity is important for providing chlorophyll with the disassembling property induced under weakly acidic conditions. In this study, we synthesized four chlorophyll‒peptide conjugates with different numbers of lysine and histidine residues, namely, Chl-H5, Chl-(HK)2H, Chl-(KH)2K, and Chl-K5 (Scheme 1, upper, right), to achieve both water dispersibility and pH responsiveness (acid-activating properties) of their aggregates.
Naturally occurring chlorophyll-a was extracted from Spirulina, and pyropheophorbide-a was prepared via its demetallation, demethoxycarbonylation at the 132-position, and hydrolysis of the 172-esterifying group [28, 38]. Although pheophorbide-a has often been used as a photosensitizer, we chose the chemically stable pyropheophorbide-a without the methoxycarbonyl group at the 132-position in the highly reactive β-keto-ester moiety. Peptides were synthesized on a resin via solid-phase synthesis, and the free (deprotected) N-terminus of the peptides was condensed with pyropheophorbide-a, which possesses a carboxy group. Chlorophyll‒peptide conjugates were obtained by cleavage from the resin via 95% (v/v) TFA–H2O (Scheme 1). The conjugates were characterized using 1H-NMR spectroscopy and LDI-TOF spectrometry (the experimental details are described in the Experimental Section, and their spectra are shown in Figs. S1–S4 in the Supplemental Information).
Self-aggregation of chlorophyll‒peptide conjugates
The morphology and size of the aggregates of the chlorophyll‒peptide conjugates were evaluated via TEM. The conjugate was dissolved in a small amount of ethanol, dried to form a thin film, and then rehydrated with PBS at pH 7.4, followed by sonication to prepare self-aggregates. The dispersion was cast onto a carbon-coated copper grid and incubated for 5 min, and excess PBS was removed to prepare TEM samples of the aggregated conjugates. Nanoparticles were observed in the aggregates of Chl-H5, Chl-(HK)2H, and Chl-(KH)2K prepared in PBS at pH 7.4, with average particle diameters of 329 ± 335 (33–2800 nm), 73 ± 50, and 251 ± 202 nm determined by TEM measurements, respectively (Fig. 2). The larger standard deviation value is due to the variation in the particle size. In particular, the aggregates of Chl-H5 and Chl-(KH)2K were widely distributed, ranging from large aggregates larger than 1 μm to small aggregates with diameters of several dozen nm. For the Chl-K5 aggregates, no nanoparticles could be identified; instead, ameba-like aggregates were observed. We also attempted to determine the size dispersion by DLS but were unable to measure it successfully because the wavelength of the laser used overlapped with the Qy absorption band of the conjugates.
Chl-H5, bearing a peptide consisting only of histidine, which is hydrophobic under neutral conditions, exhibited high aggregation in aqueous solution and formed large amorphous particles. In contrast, Chl-K5, which contains only highly hydrophilic lysine residues, did not form nanoparticles because of its lower aggregation propensity. These results suggest that the ratio of histidine to lysine residues significantly affects the size and morphology of the aggregates. Since particles with diameters of 10–200 nm are known to accumulate in tumor tissues [9, 12], Chl-(HK)2H aggregates, with an average particle size of 73 nm, are expected to act as agents capable of cancer-selective accumulation.
pH-dependent photophysical properties
To investigate the acid responsiveness of the aggregated conjugates, their pH-dependent photophysical properties were examined. All the monomeric conjugates in ethanol presented two sharp and strong absorption peaks at 410 and 666 nm, referred to as the Soret and Qy bands [28, 38], respectively (Fig. 3a, black lines). The UV–vis absorption spectra of the aggregates in PBS at pH 7.4 were broadened and slightly redshifted, with Chl-H5 displaying the most broadened and shifted spectrum (Fig. 3a, blue lines). These spectral changes are often observed when chlorophyll and its derivatives form disordered aggregates, implying that the nanoparticles of the conjugate, as shown in Fig. 2, are micelle-like aggregates built by the solvophobic effect. A comparison of the absorption spectra of the aggregates prepared under weakly acidic and neutral conditions revealed an increase in the absorption peak intensity with decreasing pH for Chl-H5 (Fig. 3a, blue to red lines). The aggregation of Chl-(HK)2H and Chl-(KH)2H, which contain three histidine residues, also slightly increased the Soret absorption bands in acidic PBS. Owing to the protonation of the imidazolyl group in the histidine side chain under acidic conditions, the conjugates produce electrostatic repulsion between peptide moieties in addition to increasing the hydrophilicity. Thus, the slight increase in absorption intensity was attributed to the broadened absorption spectrum becoming closer to the monomer spectrum because of the partial disaggregation of the micellar aggregates caused by the electrostatic repulsion and reduction in the hydrophobicity of the conjugates. Chl-K5, lacking any histidyl residues, revealed no change in the absorption spectrum with pH.
Although the determination of the pKa of the conjugates by pH titration experiments did not succeed unfortunately, the disassembly of the aggregated conjugates in response to increasing acidity in an aqueous solution was monitored via fluorescence emission spectra. Samples for fluorescence measurements were prepared by diluting the dispersion used for UV–vis absorption spectroscopy ten-fold with PBS at pH 5.8 or 7.4. All the fluorescence emission spectra of the aggregated conjugates revealed an increase in the monomer-derived fluorescence emission at 668 nm with decreasing pH (Fig. 3b). Almost no increase in the absorption intensity with decreasing pH was observed for Chl-K5, but changes in the fluorescence emission spectrum were detected, implying that the amino group of the lysine side chain contributed to acid-induced disaggregation. TEM images of the conjugates prepared in different pH PBS solutions also indicated acid-induced disaggregation. Compared with the TEM images of the aggregates prepared under neutral conditions, the images of the aggregates prepared in PBS at pH 5.8 revealed transformation into amoeba-like aggregates or an increase in the aggregate size (Fig. S5). These transformations associated with acidification are caused by partial disaggregation due to electrostatic repulsion induced by protonation of the peptide moiety on the conjugates.
The fluorescence emission intensity of the conjugates in PBS tended to increase with decreasing number of histidine residues, regardless of pH. However, the incremental ratios of the luminescence of Chl-H5, Chl-(HK)2H, Chl-(KH)2K, and Chl-K5 with increasing acidity (FL intensity at 668 nm at pH 5.8/FL intensity at 668 nm at pH 7.4) were 2.1, 2.8, 3.9, and 2.3, respectively, and were not proportional to the number of histidine residues.
ROS generation
The amount of ROS, particularly singlet oxygen, generated by light irradiation of the aggregates of chlorophyll‒peptide conjugates under acidic or neutral conditions was estimated by fluorescence emission spectral measurements with the SOSG probe. Since SOSG transforms into a fluorophore with emission maxima at approximately 530 nm upon reacting with singlet oxygen, the amount of singlet oxygen produced by light irradiation of the aggregated conjugates can be evaluated by an increase in the fluorescence emission intensity [39]. The dispersion of aggregated conjugates in PBS at pH 5.8 or 7.4 containing SOSG was prepared, and the SOSG samples were either irradiated with light (λ = 420 nm) or left in the dark for 5 min. ROS generation was assessed by comparing the fluorescence emission spectra of photoirradiated and non-photoirradiated SOSG samples. All the fluorescence emission spectra of the SOSG samples at pH 5.8 showed increased intensity at 528 nm upon photoirradiation (Fig. 4, red dotted to solid lines), indicating that singlet oxygen is produced via photoexcitation of the conjugates and subsequent energy transfer to oxygen. In contrast, the increase in emission at 528 nm upon light irradiation of the SOSG samples at pH 7.4 was reduced (Fig. 4, blue dotted to solid lines). Specifically, the SOSG samples containing the conjugates Chl-H5, Chl-(HK)2H, and Chl-(KH)2K, which have histidine residues, showed hardly any spectral changes under light irradiation. These findings suggest that these conjugates can significantly reduce the amount of ROS generation induced by light irradiation under neutral conditions, which is promising for reducing phototoxicity in normal tissues.
Physical properties of conjugates with different peptides
The sizes of the aggregates and the photophysical properties of the chlorophyll‒peptide conjugates, which are important for tumor-selective photosensitizers, are shown in Table 1. The fluorescence emission intensity and photoinduced ROS generation of the conjugates decreased with increasing ratio of histidine residue, regardless of pH. This is attributed to the influence of the hydrophobic histidine side chains on self-aggregation and the accompanying quenching. Chl-H5, which possesses a peptide composed only of histidine, could be expected to reduce phototoxicity under neutral conditions. However, its acid-induced activation of photophysical properties was less likely to occur because the conjugate formed large aggregates due to strong hydrophobic effects. Conversely, hydrophilic Chl-K5 exhibited high fluorescence emission and ROS generation even in neutral PBS and was not inactivated. Therefore, the balance between hydrophilic and hydrophobic functional groups, as well as pH responsivity, is key to developing acid-activatable photosensitizers. Indeed, Chl-(HK)2H and Chl-(KH)2K, which contained a mixture of the two amino acids, presented greater fluorescence intensity and increased ROS generation with decreasing pH (7.4 to 5.8) than did Chl-H5 and Chl-K5. Notably, Chl-(HK)2H displayed the greatest change in singlet oxygen generation with pH (Table 1, right column) and self-assembled to form nanoparticles capable of tumor-selective accumulation based on the EPR effect (10 < 73 < 200 nm, second left column). Thus, this aggregate is expected to be a photosensitizer capable of both passive and active targeting.
Cytotoxicity of conjugates
The dark toxicity and phototoxicity of Chl-(HK)2H were investigated through cytotoxicity tests in HeLa cells [37]. Samples for the PI assay were prepared by adding PI and Chl-(HK)2H aggregates to HeLa cells in media adjusted to pH 5.8 and 7.4, resulting in final conjugate concentrations of 0.1 and 1 µM, respectively. The samples were incubated under light-shielded and illuminated conditions (λ = 420 nm) for 10, 20, and 30 min, and cell viability was determined by counting the number of living and dead cells via fluorescence microscopy (Figs. S6 and S7). The cell viability of the samples incubated in the dark, irrespective of pH or concentration, was greater than 98%, which was almost identical to that of the control samples without the conjugate (Fig. 5). Even with a 10 µM concentration of the conjugate incubated in the dark, the cell viability remained higher than 90%, indicating that Chl-(HK)2H did not exhibit dark toxicity (Fig. S8). When the samples with 0.1 and 1 µM Chl-(HK)2H were photoirradiated at pH 5.8, the cell viability gradually decreased, eventually reaching 50% and 7%, respectively, after 30 min of incubation. Since no cell death was observed after light irradiation of the control sample, these results demonstrated that the ROS generated by light irradiation of Chl-(HK)2H induced cell death (Fig. 5).
A phototoxicity study of the PI assay samples at pH 7.4 was conducted similarly. After 30 min of light irradiation of the 1 µM sample, the cell viability decreased to 4%, which was almost identical to that at pH 5.8, revealing high cytotoxicity even under neutral conditions with high concentrations of Chl-(HK)2H. However, the cell viability of the 0.1 µM sample at pH 7.4 decreased less, which was significantly different from the cytotoxicity results in an acidic medium. Therefore, low concentrations of Chl-(HK)2H function as photosensitizers capable of reducing cytotoxicity under neutral conditions, similar to normal tissue, and inducing cell death under weakly acidic conditions, such as in tumor tissue.
Conclusion
We designed and synthesized chlorophyll‒peptide conjugates Chl-H5, Chl-(HK)2H, Chl-(KH)2K, and Chl-K5 containing histidine and/or lysine residues to develop photosensitizers capable of both cancer-selective accumulation through passive targeting and acid-activatable phototoxicity. The ratio of hydrophilic lysine to hydrophobic histidine significantly affected the size of the self-aggregates of the conjugates and their pH-dependent photophysical properties. In particular, Chl-(HK)2H self-assembled into nanoparticles with a diameter of approximately 70 nm, which are expected to achieve tumor-selective accumulation based on the EPR effect and a reduction in ROS generation via self-aggregation under neutral conditions. In contrast, the aggregates of the conjugates partially disaggregated, and the photosensitizing activity increased with decreasing pH. Cytotoxicity testing using HeLa cells revealed that Chl-(HK)2H exhibited negligible dark toxicity regardless of the aqueous pH and sample concentration. Cell death was observed when a low concentration of the conjugate was exposed to light irradiation under weakly acidic conditions, confirming its function as a photosensitizer. We propose that the conjugate is useful as a photosensitizer capable of both passive targeting and acid activation based on the characteristics of tumor tissue. We expect that this study will contribute to the development of cancer-selective photosensitizers.
References
Juarranz Á, Jaén P, Sanz-Rodríguez F, Cuevas J, González S. Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 2008;10:148–54. https://doi.org/10.1007/s12094-008-0172-2
Li X, Lee S, Yoon J. Supramolecular photosensitizers rejuvenate photodynamic therapy. Chem Soc Rev 2018;47:1174–88. https://doi.org/10.1039/C7CS00594F
Desai VM, Choudhary M, Chowdhury R, Singhvi G. Photodynamic therapy induced mitochondrial targeting strategies for cancer treatment: emerging trends and insights. Mol Pharm 2024;21:1591–608. https://doi.org/10.1021/acs.molpharmaceut.3c01185
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889–905. https://doi.org/10.1093/jnci/90.12.889
Usuda J, Tsutsui H, Honda H, Ichinose S, Ishizumi T, Hirata T, et al. Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy. Lung Cancer 2007;58:317–23. https://doi.org/10.1016/j.lungcan.2007.06.026
Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiag Photodyn Ther 2010;7:61–75. https://doi.org/10.1016/j.pdpdt.2010.02.001
Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011;61:250–81. https://doi.org/10.3322/caac.20114
Zalar GL, Poh-Fitzpatrick M, Krohn DL, Jacobs R, Harber LC. Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin. Arch Dermatol 1977;113:1392–7. https://doi.org/10.1001/archderm.1977.01640100070012
Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387–92.
Griffiths JR. Are cancer cells acidic? Br J Cancer 1991;64:425–7. https://doi.org/10.1038/bjc.1991.326
Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 2011;11:671–7. https://doi.org/10.1038/nrc3110
Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011;63:136–51. https://doi.org/10.1016/j.addr.2010.04.009
Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev 2015;115:1990–2042. https://doi.org/10.1021/cr5004198
Zhou X, Liang H, Jiang P, Zhang KY, Liu S, Yang T, et al. Multifunctional phosphorescent conjugated polymer dots for hypoxia imaging and photodynamic therapy of cancer cells. Adv Sci 2016;3:1500155 https://doi.org/10.1002/advs.201500155
Dai X, Du T, Han K. Engineering nanoparticles for optimized photodynamic therapy. ACS Biomater Sci Eng 2019;5:6342–54. https://doi.org/10.1021/acsbiomaterials.9b01251
Prieto-Montero R, Arbeloa T, Martínez-Martínez V. Photosensitizer-mesoporous silica nanoparticles combination for enhanced photodynamic therapy. Photochem Photobiol 2023;99:882–900. https://doi.org/10.1111/php.13802
Singh N, Won M, An J, Yoon C, Kim D, Lee SJ, et al. Advances in covalent organic frameworks for cancer phototherapy. Coord Chem Rev 2024;506:215720 https://doi.org/10.1016/j.ccr.2024.215720
Zhang X, Ma Y, Shi Y, Jiang L, Wang L, Rashid UH, et al. Advances in liposomes loaded with photoresponse materials for cancer therapy. Biomed Pharmacother 2024;174:116586 https://doi.org/10.1016/j.biopha.2024.116586
Pan ZY, Ling BF, Zhi YS, Yao DH, Li CY, Wu HQ, et al. Near-infrared AIE-active phosphorescent iridium(iii) complex for mitochondria-targeted photodynamic therapy. Dalton Trans 2023;52:1291–300. https://doi.org/10.1039/D2DT03861G
Kim SH, Lee Y, Lim SG, Lee C, Park JS, Koo H. Pheophorbide a-loaded casein micelle for in vivo drug delivery and efficient photodynamic therapy. J Drug Deliv Sci Tech 2024;95:105598 https://doi.org/10.1016/j.jddst.2024.105598
Luby BM, Walsh CD, Zheng G. Advanced photosensitizer activation strategies for smarter photodynamic therapy beacons. Angew Chem Int Ed 2019;58:2558–69. https://doi.org/10.1002/anie.201805246
Sun B, Chang R, Cao S, Yuan C, Zhao L, Yang H, et al. Acid-activatable transmorphic peptide-based nanomaterials for photodynamic therapy. Angew Chem Int Ed 2020;59:20582–8. https://doi.org/10.1002/anie.202008708
Shao L, Pan Y, Hua B, Xu S, Yu G, Wang M, et al. Constructing adaptive photosensitizers via supramolecular modification based on pillararene host–guest interactions. Angew Chem Int Ed 2020;59:11779–83. https://doi.org/10.1002/anie.202000338
Liu X, Zhan W, Gao G, Jiang Q, Zhang X, Zhang H, et al. Apoptosis-amplified assembly of porphyrin nanofiber enhances photodynamic therapy of oral tumor. J Am Chem Soc 2023;145:7918–30. https://doi.org/10.1021/jacs.2c13189
Mu R, Zhu D, Abdulmalik S, Wijekoon S, Wei G, Kumbar SG. Stimuli-responsive peptide assemblies: Design, self-assembly, modulation, and biomedical applications. Bioact Mater 2024;35:181–207. https://doi.org/10.1016/j.bioactmat.2024.01.023
Liu J, Kang DW, Fan Y, Nash GT, Jiang X, Weichselbaum RR, et al. Nanoscale covalent organic framework with staggered stacking of phthalocyanines for mitochondria-targeted photodynamic therapy. J Am Chem Soc 2024;146:849–57. https://doi.org/10.1021/jacs.3c11092
Guo Z, Nana W, Xiaowen H, Jinlong S, Xiangqi Y, Chen X, et al. Self-amplified activatable nanophotosensitizers for HIF-1α inhibition-enhanced photodynamic therapy. Nanoscale 2024;16:4239–48. https://doi.org/10.1039/D3NR05245A
Tamiaki H, Kunieda M. Photochemistry of chlorophylls and their synthetic analogs. In Handbook of Porphyrin Science, vol 11, chap. 51, pp 223–90, (2011). https://doi.org/10.1142/9789814322386_0003
Hoi SW-H, Wong HM, Chan JY, Yue GG, Tse GM, Law BK, et al. Photodynamic therapy of pheophorbide a inhibits the proliferation of human breast tumour via both caspase-dependent and -independent apoptotic pathways in in vitro and in vivo models. Phytother Res 2012;26:734–42. https://doi.org/10.1002/ptr.3607
Kim KS, Kim J, Lee JY, Matsuda S, Hideshima S, Mori Y, et al. Stimuli-responsive magnetic nanoparticles for tumor-targeted bimodal imaging and photodynamic/hyperthermia combination therapy. Nanoscale 2016;8:11625–34. https://doi.org/10.1039/C6NR02273A
Wang W, Zhu C, Zhang B, Feng Y, Zhang Y, Li J. Self-assembled nano-PROTAC enables near-infrared photodynamic proteolysis for cancer therapy. J Am Chem Soc 2023;145:16642–9. https://doi.org/10.1021/jacs.3c04109
Li L-L, Zeng Q, Liu WJ, Hu XF, Li Y, Pan J, et al. Quantitative analysis of caspase-1 activity in living cells through dynamic equilibrium of chlorophyll-based nano-assembly modulated photoacoustic signals. ACS Appl Mater Interfaces 2016;8:17936–43. https://doi.org/10.1021/acsami.6b05795
Li Y, Zhang F, Wang X, Chen C, Fu X, Tian W, et al. Pluronic micelle-encapsulated red-photoluminescent chlorophyll derivative for biocompatible cancer cell imaging. Dyes Pigm 2017;136:17–23. https://doi.org/10.1016/j.dyepig.2016.08.018
Zhu Y-S, Tang K, Lv J. Peptide–drug conjugate-based novel molecular drug delivery system in cancer. Trends Pharmacol Sci 2021;42:857–69. https://doi.org/10.1016/j.tips.2021.07.001
Yang S, Wang M, Wang T, Sun M, Huang H, Shi X, et al. Self-assembled short peptides: Recent advances and strategies for potential pharmaceutical applications. Mater Today Bio 2023;20:100644 https://doi.org/10.1016/j.mtbio.2023.100644
Liu H, Carter PJH, Laan AC, Eelkema R, Denkova AG. Singlet oxygen sensor green is not a suitable probe for 1O2 in the presence of ionizing radiation. Sci Rep. 2019;9:8393 https://doi.org/10.1038/s41598-019-44880-2
Souchier C, Ffrench M, Benchaib M, Catallo R, Bryon PA. Methods for cell proliferation analysis by fluorescent image cytometry. Cytometry 1995;20:203–9. https://doi.org/10.1002/cyto.990200303
Tamiaki H, Takeuchi S, Tsudzuki S, Miyatake T, Tanikaga R. Self-aggregation of synthetic zinc chlorins with a chiral 1-hydroxyethyl group as a model for in vivo epimeric bacteriochlorophyll-c and d aggregates. Tetrahedron 1998;54:6699–718. https://doi.org/10.1016/S0040-4020(98)00338-X
Kim S, Fujitsuka M, Majima T. Photochemistry of singlet oxygen sensor green. J Phys Chem B 2013;117:13985–92. https://doi.org/10.1021/jp406638g
Acknowledgements
This work was financially supported by The Foundation of Public Interest of Tatematsu (SM), The Uehara Memorial Foundation (SM), and JSPS Grant-in-Aid for Transformative Research Areas A “Bottom-up Biotech” JP21H05226 (ST).
Funding
Open Access funding provided by Nagoya Institute of Technology.
Author information
Authors and Affiliations
Contributions
SM designed the experiments and prepared the manuscript. The experiments were performed by MN and SM. The cytotoxicity test was performed by MN and MY. All the authors discussed and edited the manuscript and approved the final version for submission.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Nagatani, M., Yoshikawa, M., Tsukiji, S. et al. Acid-activatable photosensitizers for photodynamic therapy using self-aggregates of chlorophyll‒peptide conjugates. Polym J (2024). https://doi.org/10.1038/s41428-024-00961-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41428-024-00961-2